Urgent recall of 2 types of eye drops containing banned substances

The Drug Administration of Vietnam requires the registration companies and manufacturers of drugs in the list of drugs whose registration numbers have been revoked to carry out the recall.

On March 12, the Drug Administration of Vietnam (Ministry of Health) announced that Dr. Truong Quoc Cuong, Director of the Drug Administration of Vietnam, signed Decision No. 101/QD-QLD on withdrawing the registration numbers of drugs containing the active ingredient Gatifloxacin from the list of drugs granted registration numbers in Vietnam. Gatifloxacin is on the list of raw materials and finished drugs banned from import for human use.

.

Accordingly, Zymar eye drops, registered by Allergan, Inc. (USA), manufactured by Allergan Sales, LLC (USA), and Efticati eye drops, registered and manufactured by 3/2 Pharmaceutical Joint Stock Company (HCMC), had their registration numbers revoked.

The Drug Administration of Vietnam requires the registration company and the manufacturer of drugs in the list of drugs whose registration numbers have been revoked to coordinate with drug importers and distributors to recall all drugs manufactured (for domestic drugs) and imported into Vietnam (for foreign drugs) before the effective date of this Decision and report the recall results in accordance with current regulations.

According to VOV.VN